357 related articles for article (PubMed ID: 22099761)
1. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
2. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
[TBL] [Abstract][Full Text] [Related]
3. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
4. Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts.
Tian L; Gao J; Weng G; Yi H; Tian B; O'Brien TD; Guo Z
Transpl Int; 2011 Aug; 24(8):856-64. PubMed ID: 21627696
[TBL] [Abstract][Full Text] [Related]
5. Activation of GPR119 Stimulates Human β-Cell Replication and Neogenesis in Humanized Mice with Functional Human Islets.
Ansarullah ; Free C; Christopherson J; Chen Q; Gao J; Liu C; Naji A; Rabinovitch A; Guo Z
J Diabetes Res; 2016; 2016():1620821. PubMed ID: 27413754
[TBL] [Abstract][Full Text] [Related]
6. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
Flock G; Holland D; Seino Y; Drucker DJ
Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
[TBL] [Abstract][Full Text] [Related]
7. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
8. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
[TBL] [Abstract][Full Text] [Related]
9. β-Cell Inactivation of
Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
[TBL] [Abstract][Full Text] [Related]
10. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
11. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.
Ansarullah ; Lu Y; Holstein M; DeRuyter B; Rabinovitch A; Guo Z
PLoS One; 2013; 8(1):e53345. PubMed ID: 23382843
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.
Ferrer-Garcia JC; Merino-Torres JF; Pérez Bermejo G; Herrera-Vela C; Ponce-Marco JL; Piñon-Selles F
Cell Transplant; 2003; 12(8):849-57. PubMed ID: 14763504
[TBL] [Abstract][Full Text] [Related]
13. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
14. Improved transplantation outcome through delivery of DNA encoding secretion signal peptide-linked glucagon-like peptide-1 into mouse islets.
Chae HY; Lee M; Hwang HJ; Kim HA; Kang JG; Kim CS; Lee SJ; Ihm SH
Transpl Int; 2013 Apr; 26(4):443-52. PubMed ID: 23346912
[TBL] [Abstract][Full Text] [Related]
15. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.
Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB
Islets; 2010; 2(1):18-23. PubMed ID: 21099289
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.
Korsgren O; Jansson L; Sandler S; Andersson A
J Clin Invest; 1990 Dec; 86(6):2161-8. PubMed ID: 2254465
[TBL] [Abstract][Full Text] [Related]
17. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function.
Merino JF; Nacher V; Raurell M; Aranda O; Soler J; Montanya E
Diabetologia; 1997 Sep; 40(9):1004-10. PubMed ID: 9300236
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for recipient precursor cells replenishing β-cells in transplanted islets.
Hamamoto Y; Akashi T; Inada A; Bonner-Weir S; Weir GC
Cell Transplant; 2010; 19(12):1563-72. PubMed ID: 20719077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
